Oral Oncology
Volume 37, Issue 4 , Pages 333-340 , June 2001

Telomerase and oral cancer

Received 10 October 2000 ,Accepted 27 October 2000.

References 

  1. Harley CB. Telomere loss: mitotic clock or genetic time bomb?. Mutation Research. 1991;256:271–282
  2. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. European Journal of Cancer. 1997;33:787–791
  3. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. New England Journal of Medicine. 1993;328:184–194
  4. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. Journal of Molecular Biology. 1992;225:951–960
  5. Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569–573
  6. Blackburn EH. Telomerases. Annual Review of Biochemistry. 1992;61:113–129
  7. Greider CW. Telomere length regulation. Annual Review of Biochemistry. 1996;65:337–365
  8. Kozik A, Bradbury EM, Zalensky A. Increased telomere size in sperm cells of mammals with long terminal (TTAGGG)n arrays. Molecular Reproduction and Development. 1998;51:98–104
  9. van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature. 1997;385:740–743
  10. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Shaefer MR, Schnapp G, et al. Control of human telomere length by TRF1 and TRF2. Molecular and Cellular Biology. 2000;20:1659–1668
  11. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 1998;92:401–413
  12. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell. 1985;43:405–413
  13. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521–529
  14. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al.  Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015
  15. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al.  The RNA component of human telomerase. Science. 1995;269:1236–1241
  16. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, et al.  A mammalian telomerase-associated protein. Science. 1997;275:973–977
  17. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 1997;88:875–884
  18. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, et al.  Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;277:955–959
  19. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Experimental Cell Research. 1965;37:614–636
  20. Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Experimental Gerontology. 1992;27:383–389
  21. Shay JW, Wright WE, Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochimica et Biophysica Acta. 1991;1072:1–7
  22. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Medicine. 1997;3:1271–1274
  23. Goldstein S, Moerman EJ, Soeldner JS, Gleason RE, Barnett DM. Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors. Science. 1978;199:781–782
  24. Ishikawa F. Aging clock: the watchmaker’s masterpiece. Cellular and Molecular Life Sciences. 2000;57:698–704
  25. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al.  Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–352
  26. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genetics. 1997;17:498–502
  27. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinoma. Nature Genetics. 1998;18:65–68
  28. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, et al.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997;90:785–795
  29. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Research. 1998;58:622–625
  30. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase. Genes and Development. 1998;12:1769–1774
  31. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, et al.  Direct activation of TERT transcription by c-MYC. Nature Genetics. 1999;21:220–224
  32. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, et al.  Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Research. 1999;59:551–557
  33. Horikawa I, Cable PL, Afshari C, Barrett JC. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Research. 1999;59:826–830
  34. Greenberg RA, O’Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 1999;18:1219–1226
  35. Falchetti ML, Falcone G, D’Ambrosio E, Verna R, Alema S, Levi A. Induction of telomerase activity in v-myc-transformed avian cells. Oncogene. 1999;18:1515–1519
  36. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 1996;380:79–82
  37. Stoppler H, Hartmann DP, Sherman L, Schlegel R. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. Journal of Biological Chemistry. 1997;272:13 332–13 337
  38. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 1998;396:84–88
  39. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature. 1999;400:464–468
  40. Fujimoto K, Takahashi M. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA. Biochemical and Biophysical Research Communications. 1997;241:775–781
  41. Yin L, Hubbard AK, Giardina C. NF-kappaB regulates transcription of the mouse telomerase catalytic subunit. Journal of Biological Chemistry. 2000;275:36671–36675
  42. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, et al.  Estrogen activates telomerase. Cancer Research. 1999;59:5917–5921
  43. Tanaka H, Shimizu M, Horikawa I, Kugoh H, Yokota J, Barrett JC, et al.  Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region. Genes, Chromosomes and Cancer. 1998;23:123–133
  44. Cuthbert AP, Bond J, Trott DA, Gill S, Broni J, Marriott A, et al.  Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. Journal of National Cancer Institute. 1999;91:37–45
  45. Oh S, Song Y, Yim J, Kim TK. The Wilms’ tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. Journal of Biological Chemistry. 1999;274:37473–37478
  46. Oh S, Song YH, Yim J, Kim TK. Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene. 2000;19:1485–1490
  47. Gunes C, Lichtsteiner S, Vasserot AP, Englert C. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Research. 2000;60:2116–2121
  48. Cong YS, Bacchetti S. Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. Journal of Biological Chemistry. 2000;275:35665–35668
  49. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Research. 1998;58:4168–4172
  50. Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. International Journal of Cancer. 2000;85:330–335
  51. Takubo K, Nakamura K, Izumiyama N, Mafune K, Tanaka Y, Miyashita M, et al.  Telomerase activity in esophageal carcinoma. Journal of Surgical Oncology. 1997;66:88–92
  52. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al.  Telomerase activity in gastric cancer. Cancer Research. 1995;55:3258–3262
  53. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al.  Telomerase activity in small-cell and non-small-cell lung cancers. Journal of National Cancer Institute. 1995;87:895–902
  54. Li ZH, Salovaara R, Aaltonen LA, Shibata D. Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers. American Journal of Pathology. 1996;148:1075–1079
  55. Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology. 1997;112:493–500
  56. Landberg G, Nielsen NH, Nilsson P, Emdin SO, Cajander J, Roos G. Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Research. 1997;57:549–554
  57. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene. 1996;13:161–166
  58. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, et al.  Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Research. 1997;57:326–331
  59. Yan P, Coindre JM, Benhattar J, Bosman FT, Guillou L. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Research. 1999;59:3166–3170
  60. Broccoli D, Joung JW, DeLange T. Telomerase activity in normal and malignant hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America. 1995;92:9082–9086
  61. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al.  Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. Journal of Immunology. 1995;155:3711–3715
  62. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Research. 1997;57:610–614
  63. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and non malignant skin conditions. Journal of Investigative Dermatology. 1996;106:759–765
  64. Kannan S, Tahara H, Yokozaki H, Mathew B, Nalinakumari KR, Nair MK, et al.  Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epidemiol Biomarkers Prev. 1997;6:413–420
  65. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:6476–6481
  66. Yoshida K, Sugino T, Tahara H, Woodman A, Bolodeoku J, Nargund V, et al.  Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer. 1997;79:362–369
  67. Ito H, Kyo S, Kanaya T, Takakura M, Koshida K, Namiki M, et al.  Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clinical Cancer Research. 1998;4:2807–2810
  68. Yokota K, Kanda K, Inoue Y, Kanayama H, Kagawa S. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma. British Journal of Urology. 1998;82:727–732
  69. Yoshida K, Sugino T, Goodison S, Warren BF, Nolan D, Wadsworth S, et al.  Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. British Journal of Cancer. 1997;75:548–553
  70. Yang SC, Lee DH, Hong SJ, Chung BH, Kim IY. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes. Yonsei Medical Journal. 1997;38:155–159
  71. Iwao T, Hiyama E, Yokoyama T, Tsuchida A, Hiyama K, Murakami Y, et al.  Telomerase activity for the preoperative diagnosis of pancreatic cancer. Journal of National Cancer Institute. 1997;89:1621–1623
  72. Sumida T, Sogawa K, Hamakawa H, Sugita A, Tanioka H, Ueda N. Detection of telomerase activity in oral lesions. Journal of Oral Pathology and Medicine. 1998;27:111–115
  73. Yang CT, Lee MH, Lan RS, Chen JK. Telomerase activity in pleural effusions: diagnostic significance. Journal of Clinical Oncology. 1998;16:567–573
  74. Califano J, Ahrendt SA, Meininger G, Westra WH, Koch WM, Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Research. 1996;56:5720–5722
  75. Haugen BR, Nawaz S, Markham N, Hashizumi T, Shroyer AL, Werness B, et al.  Telomerase activity in benign and malignant thyroid tumors. Thyroid. 1997;7:337–342
  76. Aogi K, Kitahara K, Buley I, Backdahl M, Tahara H, Sugino T, et al.  Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates. Clinical Cancer Research. 1998;4:1965–1970
  77. Pearson AS, Gollahon LS, O’Neal NC, Saboorian H, Shay JW, Fahey TJ. Detection of telomerase activity in breast masses by fine-needle aspiration. Annals of Surgical Oncology. 1998;5:186–193
  78. Zeiger MA, Smallridge RC, Clark DP, Liang CK, Carty SE, Watson CG, et al.  Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Surgery. 1999;126:1195–1198
  79. Kondo Y, Koga S, Komata T, Kondo S. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component. Oncogene. 2000;19:2205–2211
  80. Strahl C, Blackburn EH. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Molecular and Cellular Biology. 1996;16:53–65
  81. Yegorov YE, Chernov DN, Akimov SS, Bolsheva NL, Krayevsky AA, Zelenin AV. Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts. FEBS Letters. 1996;389:115–118
  82. Kanazawa Y, Ohkawa K, Ueda K, Mita E, Takehara T, Sasaki Y, et al.  Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications. 1996;225:570–576
  83. Yokoyama Y, Takahashi Y, Shinohara A, Wan X, Takahashi S, Niwa K, et al.  The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Biochemical and Biophysical Research Communications. 2000;273:316–321
  84. Yamakuchi M, Nakata M, Kawahara K, Kitajima I, Maruyama I. New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. Cancer Letters. 1997;119:213–219
  85. Sogawa K, Sumida T, Hamakawa H, Yamada T, Matsumoto K, Matsuda M, et al.  Inhibitory effect of a marine microalgal polysaccharide on the telomerase activity in K562 cells. Research Communications in Molecular Pathology and Pharmacology. 1998;99:259–265
  86. Ku WC, Cheng AJ, Wang TC. Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochemical and Biophysical Research Communications. 1997;241:730–736
  87. Sharma S, Raymond E, Soda H, Sun D, Hilsenbeck SG, Sharma A, et al.  Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Annals of Oncology. 1997;8:1063–1074
  88. Davis BM, Koc ON, Lee K, Gerson SL. Current progress in the gene therapy of cancer. Current Opinion in Oncology. 1996;8:499–508
  89. Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, et al.  A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. Human Gene Therapy. 2000;11:1397–1406
  90. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature. 1998;392:569–574
  91. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, et al.  Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 1999;96:701–712
  92. Mao L, El-Naggar AK, Fan YH, Lee JS, Lippman SM, Kayser S, et al.  Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Research. 1996;56:5600–5604
  93. Curran AJ, St Denis K, Irish J, Gullane PJ, MacMillan C, Kamel-Reid S. Telomerase activity in oral squamous cell carcinoma. Archives of Otolaryngology Head and Neck Surgery. 1998;124:784–788
  94. Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H, Ueda N. Telomerase components as a diagnostic tool in human oral lesions. International Journal of Cancer. 1999;80:1–4
  95. Chang LY, Lin SC, Chang CS, Wong YK, Hu YC, Chang KW. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. Journal of Oral Pathology and Medicine. 1999;28:389–396
  96. Liao J, Mitsuyasu T, Yamane K, Ohishi M. Telomerase activity in oral and maxillofacial tumors. Oral Oncology. 2000;36:347–352
  97. Mutirangura A, Supiyaphun P, Trirekapan S, Sriuranpong V, Sakuntabhai A, Yenrudi S, et al.  Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Research. 1996;56:3530–3533
  98. Sumida T, Hamakawa H, Sogawa K, Bao Y, Zen H, Sugita A, et al.  Telomerase activation and cell proliferation during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Molecular Carcinogenesis. 1999;25:164–168
  99. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984;53:563–568
  100. Mao L. Leukoplakia: molecular understanding of pre-malignant lesions and implications for clinical management. Molecular Medicine Today. 1997;3:442–448
  101. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncology. 2000;36:311–327
  102. Fujita K, Kaku T, Sasaki M, Onoe T. Experimental production of lingual carcinoma in hamsters by local application of 9,10-dimethyl-1,2-benzanthracene. Journal of Dental Research. 1973;52:327–332
  103. Chang KW, Sarraj S, Lin SC, Tsai PI, Solt D. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis. 2000;21:1441–1451
  104. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Cancer. 1996;78:1235–1240
  105. Noguchi S, Hiratsuka M, Furukawa H, Aihara T, Kasugai T, Tamura S, et al.  Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Japanese Journal of Cancer Research. 1996;87:650–654
  106. Stenman J, Lintula S, Hotakainen K, Vartiainen J, Lehvaslaiho H, Stenman UH. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix. International Journal of Cancer. 1997;74:75–80
  107. Hamakawa H, Fukizumi M, Bao Y, Sumida T, Onishi A, Tanioka H, et al.  Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer. Clinical and Experimental Metastasis. 1999;17:593–599
  108. Wong LS, Cantrill JE, Odogwu S, Morris AG, Fraser IA. Detection of circulating tumour cells and nodal metastasis by reverse transcriptase-polymerase chain reaction technique. British Journal of Surgery. 1997;84:834–839
  109. Sumida T, Hamakawa H, Kayahara H, Zen H, Sogawa K, Tanioka H, et al.  Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy. Archives of Pathology and Laboratory Medicine. 2000;124:398–400
  110. Williams ED, Lowes AP, Williams D, Williams GT. A stem cell niche theory of intestinal crypt maintenance based on a study of somatic mutation in colonic mucosa. American Journal of Pathology. 1992;141:773–776
  111. Leary T, Jones PL, Appleby M, Blight A, Parkinson K, Stanley M. Epidermal keratinocyte self-renewal is dependent upon dermal integrity. Journal of Investigative Dermatology. 1992;99:422–430
  112. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, et al.  Telomerase activity in normal human epithelial cells. Oncogene. 1996;13:433–439

PII: S1368-8375(00)00132-9

Oral Oncology
Volume 37, Issue 4 , Pages 333-340 , June 2001

Article Tools